Diagnostics of External Ventricular Drain Infections in Neurosurgical Patients
EVD-Infect
External Ventricular Drain Infections in Neurosurgical Patients: Diagnostic and Treatment Implications
1 other identifier
observational
55
1 country
1
Brief Summary
External ventricular drains (EVD) are small tubes used in neuro-critical care inserted to measure pressure and treat acute build-up of fluid in the brain by draining the cerebrospinal fluid (CSF) in the ventricles, often following an event of traumatic or spontaneous bleeding. While essential to the care of these patients, EVDs run the risk of introducing bacteria into the brain of the patient, causing an EVD associated infection (EVDI). EVDIs are feared complications that are difficult to identify and predict in an intensive care setting. In order to allow for early identification of these infections, CSF is routinely sampled from the EVDs and its constitution analyzed for signs of infection. However, the constitution of the CSF in neuro-critical care patients are often difficult to assess as it is frequently mixed with blood that often clouds clinical decision making. No fast parameter has been found to yet reliably predict or identify these infections, resulting in excessive treatment with broad-spectrum antibiotics in this patient group. EVDI diagnostics rely on mainly CSF analyses and cultures (growth of bacteria in the laboratory). Growing bacteria in the lab may take many days and can seldom guide early decision-making for these infections. Thus, EVDI diagnostics mainly rely on the analysis of the CSF constitution. Many diagnostic criteria rely on the relationship between white and red blood cells in the CSF, with red blood cells being introduced in the CSF following the brain bleed , and white blood cells being seen as a response to infection. These criteria assume that the blood is homogeneous in the CSF. However, from computed tomography (CT) imaging of these patients, it is seen that blood can settle in the brain ventricles. In this study we aim to test the assumption that blood is homogeneously distributed in the CSF by sampling from the CSF in patients. Two samples are serially drawn allocated to a period between where patients are planned for a clinical repositioning, or not. We hypothesise that a heterogeneous distribution of blood in the CSF (as seen on CT imaging) may allow for the CSF constitution to change in serially drawn CSF samples, and that these changes may be exacerbated in repositioned patients as it may disturb the blood that has settled at the bottom of the ventricles as a result of gravity sedimentation. We further believe that these changes may affect clinical decision making and further complicate EVDI diagnostics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 26, 2019
CompletedFirst Submitted
Initial submission to the registry
January 29, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedFebruary 3, 2021
January 1, 2021
1.6 years
January 29, 2021
January 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Suspected infection
Changes in diagnostic group following standard diagnostic criteria
10 minutes
CSF cell count changes between paired samples
CSF parameter differences and variability between paired samples
10 minutes
Secondary Outcomes (1)
Other diagnostic parameters
10 minutes
Study Arms (2)
Repositioned
Allocated to sampling performed around a standard clinical repositioning (lateral side to side), or a 10 minute wait period between two serially drawn CSF samples, for each biweekly routine CSF infection surveillance sampling.
Non-repositioned
Allocated to sampling performed with a 10 minute wait period between two serially drawn CSF samples, for each biweekly routine CSF infection surveillance sampling
Interventions
no true intervention
Eligibility Criteria
Neuro Intensive Care patients in University Hospital Setting. This is the only NICU unit in the Stockholm region and covers the full population requiring ICU care with EVDs in the area
You may not qualify if:
- patients admitted with bacterial or viral CNS infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska University Hospitallead
- Region Stockholmcollaborator
Study Sites (1)
Function Preoperative Medicine and Intensive Care, Karolinska University Hospital
Stockholm, 17176, Sweden
Related Publications (1)
Badholm M, Blixt J, Glimaker M, Ternhag A, Hedlund J, Nelson DW. Cerebrospinal fluid cell count variability is a major confounding factor in external ventricular drain-associated infection surveillance diagnostics: a prospective observational study. Crit Care. 2021 Aug 11;25(1):291. doi: 10.1186/s13054-021-03715-1.
PMID: 34380543DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David W Nelson, MD,PhD
Karolinska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant, Research Group Leader
Study Record Dates
First Submitted
January 29, 2021
First Posted
February 3, 2021
Study Start
October 5, 2017
Primary Completion
April 26, 2019
Study Completion
April 26, 2019
Last Updated
February 3, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share